Highly potent, orally active diester macrocyclic human renin inhibitors
作者:Ann E. Weber、Mark G. Steiner、Philip A. Krieter、Adria E. Colletti、James R. Tata、Thomas A. Halgren、Richard G. Ball、John J. Doyle、Terry W. Schorn
DOI:10.1021/jm00099a004
日期:1992.10
moiety of inhibitor 4o with a variety of substituents led to subnanomolar inhibitors, one of which (the "3(S)-quinuclidinyl-Phe" derivative 33) lowered blood pressure 20 mmHg and completely inhibited plasma renin activity for 6 h in sodium-depleted rhesus monkeys. This compound proved to have limited bioavailability (1% in rats) due to cleavage of the serine ester bond and rapid hepatic extraction.
The invention relates to nonadepsipeptides and process for their preparation, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular bacterial infectious diseases.